CIK 0000842023 · Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411427402
- Phone
- 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-08 | HIGGINS JOHN L Director | Sale | −600 | $366.09 | $220K | 4,606 |
| 2022-06-08 | HIGGINS JOHN L Director | Option exercise · Stock Options (Right to Buy) | −600 | 3,400 | ||
| 2022-06-07 | HIGGINS JOHN L Director | Option exercise | +1,000 | $66.90 | $67K | 5,606 |
| 2022-06-07 | HIGGINS JOHN L Director | Sale | −1,000 | $364.31 | $364K | 4,606 |
| 2022-06-07 | HIGGINS JOHN L Director | Option exercise · Stock Options (Right to Buy) | −1,000 | 4,000 | ||
| 2022-06-07 | Kummeth Charles R. CHIEF EXECUTIVE OFFICER | Option exercise | +5,104 | $108.49 | $554K | 203,442 |
| 2022-06-07 | Kummeth Charles R. CHIEF EXECUTIVE OFFICER | Sale | −5,104 | $365.00 | $1.9M | 198,338 |
| 2022-06-07 | Kummeth Charles R. CHIEF EXECUTIVE OFFICER | Option exercise · Stock Option (right to buy) | −5,104 | 95,346 | ||
| 2022-05-10 | BAUMGARTNER ROBERT V Director | Purchase | +300 | $352.55 | $106K | 10,106 |
| 2022-02-08 | Kelderman Kim Pres. Diagnostics & Genom | Option exercise | +1,989 | $150.78 | $300K | 1,989 |
| 2022-02-08 | Kelderman Kim Pres. Diagnostics & Genom | Option exercise · Stock Option (Right to Buy) | −1,989 | 7,511 | ||
| 2022-02-01 | Geist William President, Protein Sciences | Grant or award · Restricted Stock Units | +2,490 | 2,490 | ||
| 2022-02-01 | Geist William President, Protein Sciences | Grant or award | +2,490 | 2,490 | ||
| 2022-02-01 | Geist William President, Protein Sciences | Grant or award · Restricted Stock Units | +840 | 840 | ||
| 2022-02-01 | Geist William President, Protein Sciences | Grant or award · Stock Option (right to buy) | +2,984 | 2,984 | ||
| 2022-02-01 | Geist William President, Protein Sciences | Grant or award · Stock Option (right to buy) | +3,978 | 3,978 | ||
| 2022-01-28 | Kummeth Charles R. Chief Executive Officer | Option exercise | +938 | $106.59 | $100K | 197,539 |
| 2022-01-28 | Kummeth Charles R. Chief Executive Officer | Option exercise | +799 | $125.05 | $100K | 198,338 |
| 2022-01-28 | Kummeth Charles R. Chief Executive Officer | Option exercise · Stock Options (Right to Buy) | −938 | 256,010 | ||
| 2022-01-28 | Kummeth Charles R. Chief Executive Officer | Option exercise · Stock Options (Right to Buy) | −799 | 194,771 |
Page 25 of 32 · 626 trades